Strategic partnerships Leverage recent co-marketing and collaboration announcements with Mikart and Khona Scientific to position Benuvia as a preferred partner for regulated formulation, API synthesis, and compliant manufacturing in controlled substances.

Regulatory leadership Highlight Benuvia's DEA and FDA registration, cGMP compliance, and multi-agency certifications (DEA, EPA, OSHA) to target customers seeking proven compliance for cannabinoids, psychedelics, and other highly regulated compounds.

End-to-end capabilities Emphasize the full suite from formulation to finished dose, serialization, packaging, warehousing, import/export, and regulatory affairs to attract clients needing turnkey development and manufacturing solutions.

U.S. manufacturing footprint Promote the Round Rock, Texas 83,000-square-foot facility as a uniquely capable domestic API and finished-dose hub for regulated substances, appealing to U.S.-focused sponsors seeking onshore production and supply reliability.

Growth trajectory Capitalize on the company’s 15+ years of experience in cannabinoids and emerging psychedelics to pursue novel therapy programs, tech-enabled process optimization, and cost-reduction narratives aligned with potential clients aiming to accelerate time-to-market.